Biden joins Sanders' campaign targeting Novo Nordisk, Eli Lilly's diabetes and obesity drug prices

In recent months, frequent pharma critic Sen. Bernie Sanders has been ratcheting up a campaign against Novo Nordisk over the price of its popular diabetes and weight loss medicines. Now, the senator has big-time backup in his fight.